General considerations for skin test procedures in the diagnosis of drug hypersensitivity

Authors

  • K. Brockow,

    1. Klinik und Poliklinik für Dermatologie und Allergologie, Muenchen, Germany;
    Search for more papers by this author
  • A. Romano,

    1. Department of Internal Medicine and Geriatrics, UCSC, Allergy Unit, CI Columbus, Rome and IRCS Oasi Maria SS, Troina, Italy;
    Search for more papers by this author
  • M. Blanca,

    1. Research Unit for Allergic Diseases, Carlos Haya Hospital, Malaga, Spain;
    Search for more papers by this author
  • J. Ring,

    1. Klinik und Poliklinik für Dermatologie und Allergologie, Muenchen, Germany;
    Search for more papers by this author
  • W. Pichler,

    1. Clinic for Rheumatology and Clinical Immunology/Allergology, Inselspital, Bern, Switzerland;
    Search for more papers by this author
  • P. Demoly

    1. Maladies Respiratoires, Hôpital Arnaud de Villeneuve, Montpellier, France
    Search for more papers by this author
    • * ENDA: European Network for Drug Allergy, the EAACI interest group on drug hypersensitivity with the following additional members: Drs W. Aberer, B. K. Ballmer-Weber, A. Barbaud, A. Bircher, J. Birnbaum, P. Campi, A. de Weck, M. Drouet, J. Fernandez, T. Fuchs, E. Gomes, J. L. Guéant, C. Gutgesell, A. Kapp, M. Kowalski, G. Marone, H. Merk, D. Moneret-Vautrin, C. Pascual-Marcos, B. Przybilla, E. Rebelo-Gomes, F. Rueff, A. Sabbah, J. Sainte Laudy, M. J. Torres, D. Vervloet, B. Wedi


Pascal Demoly
Maladies Respiratoires
INSERM U454
Hôpital Arnaud de Villeneuve
CHU de Montpellier
34295 Montpellier cedex 5
France.

Ancillary